Literature DB >> 25767624

Usefulness of Additional SPECT/CT Identifying Lymphatico-renal Shunt in a Patient with Chyluria.

Minseok Suh1, Gi Jeong Cheon1, Hyo Jung Seo2, Hyeon Hoe Kim3, Dong Soo Lee2.   

Abstract

Lymphoscintigraphy is known to be a useful and non-invasive modality for the evaluation of lymphatic abnormality. However, lymphoscintigraphy has limitations in evaluating chyluria because of its lack of anatomical information. Additional single-photon emission computed tomography (SPECT) combined with computed tomography (CT) was considered to be potentially helpful in detecting the abnormal lymphatico-renal communication. A 20-year-old male patient was referred to our hospital for evaluation of recurrent chyluria. During the third recurrence of chyluria, additional SPECT/CT along with lymphoscintigraphy was performed for evaluation. From the combined SPECT/CT images, lymphatic drainage of radiotracers to the kidney was well visualized, helping diagnosis of a patient with chyluria.

Entities:  

Keywords:  Chyluria; Radionuclide lymphoscintigraphy; SPECT/CT

Year:  2014        PMID: 25767624      PMCID: PMC4354781          DOI: 10.1007/s13139-014-0300-6

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  14 in total

1.  Chyluria.

Authors:  U T Aye; S T Aung
Journal:  Clin Radiol       Date:  1975-04       Impact factor: 2.350

2.  The role of radionuclide lymphoscintigraphy in chyluria.

Authors:  Zhibin Yuan; Qiong Luo; Libo Chen; Quanyong Luo; Ruisen Zhu
Journal:  Hell J Nucl Med       Date:  2010 Sep-Dec       Impact factor: 1.102

3.  "Milky" urine--a child with chyluria.

Authors:  J P Stalens; M Falk; R Howmann-Giles; L P Roy
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

4.  [The clinical yield of SPECT/CT for the assessment of lymphatic transport disorders. First experiences].

Authors:  M Weiss; S Landrock; J Wallmichrath; R G H Baumeister; P Bartenstein; A Frick
Journal:  Nuklearmedizin       Date:  2013-09-20       Impact factor: 1.379

5.  Case report: investigation of chyluria.

Authors:  M C Haddad; M S al Shahed; H S Sharif; U J Miola
Journal:  Clin Radiol       Date:  1994-02       Impact factor: 2.350

Review 6.  Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.

Authors:  Muhammad Kashif Rahim; Sung Eun Kim; Hyeongryul So; Hyung Jun Kim; Gi Jeong Cheon; Eun Seong Lee; Keon Wook Kang; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2014-01-22

7.  Chyluria--experience of Taipei Veterans General Hospital.

Authors:  Tzu-Ping Lin; Yen-Shen Hsu; Kuang-Kuo Chen; Alex T L Lin; Yen-Hua Chang; Howard H H Wu; William J S Huang; Junne-Yih Kuo; Hsiao-Jen Chung; Luke S Chang
Journal:  J Chin Med Assoc       Date:  2003-02       Impact factor: 2.743

Review 8.  Single-photon emission computed tomography/computed tomographyfor sentinel node mapping in breast cancer.

Authors:  Daniela B Husarik; Hans C Steinert
Journal:  Semin Nucl Med       Date:  2007-01       Impact factor: 4.446

9.  Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk.

Authors:  H J Wanebo; D Harpole; C D Teates
Journal:  Cancer       Date:  1985-03-15       Impact factor: 6.860

10.  [Studies on the current epidemiological situation of brugian filariasis in endemic areas of Korea]

Authors:  Yung Han Paik; You Jung Cho; Do Seo Koo; Han Il Ree; Jae Chul Shim
Journal:  Kisaengchunghak Chapchi       Date:  1988-12
View more
  2 in total

1.  Chyluria in non-filarial endemic areas: an internist's perspective.

Authors:  Yuyang Tan
Journal:  BMJ Case Rep       Date:  2017-10-04

2.  Unilateral pedal lymphangiography plus computed tomography angiography for location of persistent idiopathic chyle leakage not detectable by ordinary contrast computed tomography.

Authors:  Dingyi Liu; Boke Liu; Weimu Xia; Qi Tang; Haidong Wang; Jian Wang; Yanfeng Zhou; Jiashun Yu; Wenmin Li; Mingwei Wang; Wenlong Zhou; Sang Hu; Yuan Shao
Journal:  BMC Urol       Date:  2018-02-06       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.